MARTA
IBARROLA HIERRO
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Biomedicina de Sevilla (1)
2021
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252